Successful investing is a piece of art: Motilal Oswal's Raamdeo Agrawal
On investment opportunities in a market where valuations have soared, he pointed to a time-tested market wisdom: What is hated is where the biggest opportunity lies'02-01-2023
Successful investing is a piece of art: Motilal Oswal's Raamdeo Agrawal
On investment opportunities in a market where valuations have soared, he pointed to a time-tested market wisdom: What is hated is where the biggest opportunity lies'Motilal Oswal suggests this logistics stock to buy, sees upto 39% rally
The brokerage house has maintained its Buy rating on VRL Logistics sharesAdar Poonawalla-backed multibagger stock can rally up to 25%: Motilal Oswal
With huge growth opportunities for consumer and small business finance, the brokerage said that post-acquisition, PFL's management has strengthened its foundation notably by investing in technology (aiding infrastructure/processes), distribution and talent.Buy Can Fin Homes; target of Rs 630: Motilal Oswal
Motilal Oswal is bullish on Can Fin Homes recommended buy rating on the stock with a target price of Rs 630 in its research report dated December 23, 2022.MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Closure of Trading Window
We wish to inform the Exchange that pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended from time to time) and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in securities of the Company will be closed from Saturday, December 31, 2022 for the consideration and approval of Unaudited Financial Results of the Company for the quarter & nine months ended December 31, 2022. The Trading Window will open 48 hours after the declaration of the said Financial Results.Motilal Oswal to open up overseas schemes for fresh investment
The fund house will start accepting fresh subscriptions in five of its overseas funds from January 1Failure to meet USFDA compliance can endanger Indian pharma companies' US generics business, new report warns
A new report from Motilal Oswal notes that increasingly Indian pharma companies are finding it hard to meet the compliance criteria set by USFDA, leading to regulatory hurdles for the US generics market.MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time), we wish to inform the Exchange that the Finance Committee of Motilal Oswal Financial Services Limited ('the Company') at its Meeting held on December 14, 2022 has approved an allotment of 18,000 Equity Shares to those option grantees who had exercised their options under ESOP Scheme VII and ESOP Scheme IX.